From the list of genes differentially expressed between stathmin-high and -low tumours, we identified a stathmin mRNA signature composed of genes with a fold change ≤−2.0 or ≥2.0 (FDR < 0.006; 332 genes). The gene discussed is STMN1; the disease is neoplasm.